XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total Shareholders' Equity
Noncontrolling Interests
Beginning balance at Dec. 31, 2021 $ 401,100 $ 21 $ 547,726 $ (3) $ (151,545) $ 396,199 $ 4,901
Net income (loss) (43,223)       (40,722) (40,722) (2,501)
Other comprehensive income (loss) 42     42   42  
Share-based compensation expense 2,743   2,743     2,743  
Contributions from noncontrolling interests 143           143
Conversion of exchangeable notes into shares of common stock 152,538 11 152,527     152,538  
Ending balance at Mar. 31, 2022 513,343 32 702,996 39 (192,267) 510,800 2,543
Beginning balance at Dec. 31, 2021 401,100 21 547,726 (3) (151,545) 396,199 4,901
Ending balance at Sep. 30, 2022 439,375 32 708,768 274 (263,862) 445,212 (5,837)
Beginning balance at Mar. 31, 2022 513,343 32 702,996 39 (192,267) 510,800 2,543
Net income (loss) (43,805)       (41,388) (41,388) (2,417)
Other comprehensive income (loss) (33)     (33)   (33)  
Dividends declared - common stock (7,954)       (7,954) (7,954)  
Share-based compensation expense 2,818   2,818     2,818  
Adjustment for noncontrolling interests     70     70 (70)
Distributions to noncontrolling interests (2,744)           (2,744)
Ending balance at Jun. 30, 2022 461,625 32 705,884 6 (241,609) 464,313 (2,688)
Net income (loss) (17,412)       (14,294) (14,294) (3,118)
Other comprehensive income (loss) 268     268   268  
Dividends declared - common stock (7,959)       (7,959) (7,959)  
Share-based compensation expense 2,855   2,855     2,855  
Adjustment for noncontrolling interests     29     29 (29)
Distributions to noncontrolling interests (2)           (2)
Ending balance at Sep. 30, 2022 439,375 32 708,768 274 (263,862) 445,212 (5,837)
Beginning balance at Dec. 31, 2022 367,129 32 710,497 (1,054) (338,934) 370,541 (3,412)
Net income (loss) 514       2,259 2,259 (1,745)
Other comprehensive income (loss) 530     530   530  
Dividends declared - common stock (12,024)       (12,024) (12,024)  
Issuance of share of common stock associated with performance stock units net of shares withheld for tax (1,793)   (1,793)     (1,793)  
Distributions to noncontrolling interests (3)           (3)
Amortization of deferred compensation 1,843   1,843     1,843  
Compensation expense related to performance stock units 1,409   1,409     1,409  
Ending balance at Mar. 31, 2023 357,605 32 711,956 (524) (348,699) 362,765 (5,160)
Beginning balance at Dec. 31, 2022 367,129 32 710,497 (1,054) (338,934) 370,541 (3,412)
Ending balance at Sep. 30, 2023 328,970 32 717,559 957 (380,258) 338,290 (9,320)
Beginning balance at Mar. 31, 2023 357,605 32 711,956 (524) (348,699) 362,765 (5,160)
Net income (loss) (22,663)       (20,788) (20,788) (1,875)
Other comprehensive income (loss) 863     863   863  
Dividends declared - common stock (12,022)       (12,022) (12,022)  
Distributions to noncontrolling interests (1,889)           (1,889)
Amortization of deferred compensation 1,797   1,797     1,797  
Compensation expense related to performance stock units 1,410   1,410     1,410  
Ending balance at Jun. 30, 2023 325,101 32 715,163 339 (381,509) 334,025 (8,924)
Net income (loss) 12,875       13,262 13,262 (387)
Other comprehensive income (loss) 618     618   618  
Dividends declared - common stock (12,011)       (12,011) (12,011)  
Cancellation of restricted common stock (27)   (27)     (27)  
Repurchase of common stock (826)   (826)     (826)  
Adjustment for noncontrolling interests     4     4 (4)
Contributions from noncontrolling interests 117           117
Distributions to noncontrolling interests (122)           (122)
Amortization of deferred compensation 1,835   1,835     1,835  
Compensation expense related to performance stock units 1,410   1,410     1,410  
Ending balance at Sep. 30, 2023 $ 328,970 $ 32 $ 717,559 $ 957 $ (380,258) $ 338,290 $ (9,320)